Beam Therapeutics Inc
(NAS:BEAM)
$
27.08
0.72 (2.73%)
Market Cap: 2.24 Bil
Enterprise Value: 1.42 Bil
PE Ratio: 0
PB Ratio: 2.82
GF Score: 54/100 Beam Therapeutics Inc at Jefferies Gene Therapy/Editing Summit (Virtual) Transcript
Oct 27, 2021 / 08:00PM GMT
Release Date Price:
$91.79
(-2.87%)
Michael Yee
(Trades, Portfolio) LLC - Analyst
All right. Well, good afternoon and thank you for joining us on another great session here at the Jefferies virtual Gene Therapy and Gene Editing Summit. We've had a great day so far. A lot of great firesides as well with some folks who are quite familiar with our guest here on this session, Beam Therapeutics. And I was just talking with John about how David Liu had some very nice comments earlier today about where the space is going.
I wanted to, of course, introduce the CEO of Beam Therapeutics, John Evans, here with us. He has been making some great progress along single base pair gene editing, which is a next-generation technology.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot